• Graham Hughes
  • Munther A. Khamashta


At present, treatment is aimed at preventing recurrent thrombosis, using aspirin (or clopidogrel (Plavix)), low molecular weight heparin or warfarin (Coumadin).

Despite reports of the use of newer ‘biological’ agents in some cases of Hughes syndrome, experience with agents such as rituximab, as well as with the newer anticoagulants such as dabigatran, is limited.


Plasma Exchange Mycophenolate Mofetil Recurrent Pregnancy Loss Hughes Syndrome Severe Neurological Involvement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Graham Hughes
    • 1
  • Munther A. Khamashta
    • 2
  1. 1.The London Lupus CentreLondon Bridge HospitalLondonUK
  2. 2.Division of Women’s Health, Graham Hughes Lupus Research LaboratoryKing’s College LondonLondonUK

Personalised recommendations